{"nctId":"NCT03682224","briefTitle":"Exparel and Marcaine for Pain Management in Thoracoscopic Lobectomy Patients","startDateStruct":{"date":"2018-07-05","type":"ACTUAL"},"conditions":["Non Small Cell Lung Cancer","Lung Cancer Stage 1"],"count":57,"armGroups":[{"label":"Exparel","type":"ACTIVE_COMPARATOR","interventionNames":["Drug: Liposomal Bupivacaine"]},{"label":"Marcaine","type":"ACTIVE_COMPARATOR","interventionNames":["Drug: Bupivacaine-Epinephrine"]}],"interventions":[{"name":"Liposomal Bupivacaine","otherNames":[]},{"name":"Bupivacaine-Epinephrine","otherNames":[]}],"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n1. Adult at least 18 years of age\n2. Subject needs elective lobectomy for non small cell lung cancer\n3. Willing to comply with all aspects of protocol, including providing information about opioid usage for post-surgical pain and signed informed consent\n\nExclusion Criteria:\n\n1. \\< 18 years of age, \\> 80 years of age\n2. Inability or unwillingness to consent\n3. Emergency surgery\n4. Previous ipsilateral thoracic surgery\n5. Need for operative pleurectomy or pleurodesis\n6. Chronic Narcotic use\n7. Any narcotic use in the 1 month period prior to screening\n8. Allergies to bupivacaine or other local anesthetics, narcotics, NSAIDs or acetaminophen\n9. Moderate to severe hepatic impairment (ALT or AST) value greater than 3 times the upper limit of normal.\n10. Severe renal impairment or end stage renal failure disease (creatinine greater than 2.0 mg/dl).\n11. History of peptic ulcerative disease\n12. Severe chronic obstructive pulmonary disease (COPD) due to LVRS (lung-volume reduction surgery).\n13. Pregnancy\n14. Need for conversion from a Video-Assisted Thoracic Surgery procedure to an open thoracotomy\n15. Subjects who are incarcerated\n16. Subject has been treated with an experimental device within 30 days or received an experimental agent within the longer of 30 days or five half-lives. Or subject is current enrolled in another clinical trial.\n17. Unable to follow protocol directions due to organic brain or psychiatric disease.\n18. History of alcoholism or any other substance abuse, which, in the opinion of the investigator, would affect compliance with the protocol.","healthyVolunteers":false,"sex":"ALL","minimumAge":"18 Years","maximumAge":"80 Years","stdAges":["ADULT","OLDER_ADULT"]},"locations":{"multicenter":false},"periods":[],"outcomeMeasures":[{"type":"PRIMARY","title":"Total Morphine Equivalents Consumed","description":"Measured as overall intake of any drugs in the opioid class (Morphine Equivalent Dosing)","paramType":"MEDIAN","dispersionType":"Inter-Quartile Range","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"48","spread":null},{"groupId":"OG001","value":"42.7","spread":null}]}]}]},{"type":"SECONDARY","title":"VAS Pain Score","description":"Using a 10 point visual analog scale (VAS) score. The score ranges from 0 to 10. '0' represents no pain and '10' represents worst pain.","paramType":"MEDIAN","dispersionType":"Inter-Quartile Range","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"4.8","spread":null},{"groupId":"OG001","value":"5.2","spread":null}]}]}]},{"type":"SECONDARY","title":"Treatment Cost","description":"All direct cost from the date of surgery until discharge","paramType":"MEDIAN","dispersionType":"Inter-Quartile Range","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"22,775","spread":null},{"groupId":"OG001","value":"20,252","spread":null}]}]}]},{"type":"SECONDARY","title":"Pharmacy Cost","description":"Median In-hospital pharmacy cost","paramType":"MEDIAN","dispersionType":"Inter-Quartile Range","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"1052","spread":null},{"groupId":"OG001","value":"596","spread":null}]}]}]},{"type":"SECONDARY","title":"Mortality","description":"Any death occurring during primary hospital stay or prior to 30 days post surgery","paramType":"COUNT_OF_PARTICIPANTS","dispersionType":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"0","spread":null},{"groupId":"OG001","value":"0","spread":null}]}]}]},{"type":"OTHER_PRE_SPECIFIED","title":"Hospital Stay","description":null,"paramType":"MEDIAN","dispersionType":"Inter-Quartile Range","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"3.28","spread":null},{"groupId":"OG001","value":"2.45","spread":null}]}]}]},{"type":"OTHER_PRE_SPECIFIED","title":"Pneumothorax","description":"Documented pnuemothorax","paramType":"COUNT_OF_PARTICIPANTS","dispersionType":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"5","spread":null},{"groupId":"OG001","value":"6","spread":null}]}]}]},{"type":"OTHER_PRE_SPECIFIED","title":"Prolonged Air Leak","description":"Number of patients who had air leak more than 5 days post-surgery","paramType":"COUNT_OF_PARTICIPANTS","dispersionType":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"8","spread":null},{"groupId":"OG001","value":"5","spread":null}]}]}]},{"type":"OTHER_PRE_SPECIFIED","title":"Atrial Fibrillation/Other Arrhythmia","description":"Post-op arrhythmia","paramType":"COUNT_OF_PARTICIPANTS","dispersionType":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"2","spread":null},{"groupId":"OG001","value":"3","spread":null}]}]}]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":{"events":12,"n":26},"commonTop":["Acute Renal Failure","Ileus"]}}}